fibromyalgia
FIBROMYALGIA

Fibromyalgia is a clinical syndrome wherein the patient experiences generalized pain and fatigue that cannot be explained by the presence of any other disorder.
It is often considered to be psychosomatic or psychogenic in nature.
It is found in approximately 2% of the population and the prevalence increases with age, most common in women 20-55 year of age

Fibromyalgia References

  1. Arnold LM. The pathophysiology, diagnosis and treatment of fibromyalgia. Psychiatr Clin N Am. 2010 Jun;33(2):375-408. doi: 10.1016/j.psc.2010.01.001. PMID: 20385343
  2. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence based recommendations for the management of fibromyalgia syndrome. Jul 20, 2007. Ann Rheum Dis. 2008 Apr;67(4):536-541. http://ard.bmj.com/cgi/content/abstract/ard.2007.071522v1. PMID: 17644548
  3. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary. Pain Res Manag. 2013 Jun;18(3):119-126. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673928/pdf/prm18119.pdf. PMID: 23748251
  4. Hasset AL, Gevirtz RN. Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Rheum Dis Clin N Am. 2009 May;35(2):393-407. doi: 10.1016/j.rdc.2009.05.003. PMID: 19647150
  5. Jones KD, Liptan GL. Exercise interventions in fibromyalgia: clinical applications from the evidence. Rheum Dis Clin N Am. 2009 May;35(2):373-391. doi: 10.1016/j.rdc.2009.05.004. PMID: 19647149
  6. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004 Nov;292(19):2388-2395. PMID: 15547167
  7. Wolfe F, Clauw DJ, Fitzcharles M, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Research (Hoboken). 2010 May;62(5):600-610. doi: 10. doi: 10.1002/acr.20140. PMID: 20461783
  8. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-172. PMID: 2306288
  9. Mease PJ, Choy EH. Pharmacotherapy of fibromyalgia. Rheum Dis Clin N Am. 2009 May;35(2):359-372. doi: 10.1016/j.rdc.2009.06.007. PMID: 19647148
  10. Wolfe F, Rasker JJ. Fibromyalgia. In: Firestein GS, Budd RC, Harris ED Jr, et al. Kelley's Textbook of Rheumatology. 8th. Philadelphia, PA: Elsevier Inc; 2009.
  11. Goldenberg D. Clinical manifestations and diagnosis of fibromyalgia in adults. UpToDate. http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fibromyalgia-in-adults. Aug 2013. Accessed 06 Jun 2011.
  12. National Guideline Clearinghouse (NGC). Guideline summary: Guideline for the management of fibromyalgia syndrome pain in adults and children. National Guideline Clearinghouse. http://www.guideline.gov. 2005.
  13. University of Texas, School of Nursing, Family Nurse Practitioner Program. Management of fibromyalgia syndrome in adults. National Guideline Clearing House (NGC). http://www.guideline.gov/content.aspx?id=14869. May 2005
  14. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al; National Fibromyalgia Guideline Advisory Panel. Guidelines for the diagnosis and management of fibromyalgia syndrome. http://www.canadianpainsociety.ca/pdf/Fibromyalgia_Guidelines_2012.pdf. 2012. Accessed 01 Jul 2013
  15. Winfield JB. Fibromyalgia. eMedicine. http://emedicine.medscape.com/article/329838-overview.Accessed 10 Jun 2011
  16. Goldenberg D. Treatment of fibromyalgia in adults not responsive to initial therapies. UptoDate Web Site. http://www.uptodate.com/contents/treatment-of-fibromyalgia-in-adults-not-responsive-to-initial-therapies. Jan 2014. Accessed 06 Jun 2011.
  17. Goldenberg D. Initial treatment of fibromyalgia in adults. UptoDate Web Site. http://www.uptodate.com/contents/initial-treatment-of-fibromyalgia-in-adults. Jan 2014.
  18. Dymon T. Fibromyalgia. In: Dong BJ, Elliott DP, eds. Neurologic and Psychiatric Care I. Lexena, KS: American College of Clinical Pharmacy; 2015:5-18.
  19. Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL. Treatments for fibromyalgia in adult subgroups [Internet]. AHRQ Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality (US); 2015 Jan. http://www.ncbi.nlm.nih.gov/books/NBK274474/pdf/Bookshelf_NBK274474.pdf.
  20. Ablin J, Fitzcharles MA, Buskila D, et al. Treatment of fibromyalgia syndrome: recommendations of recent evidenced-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat. 2013. doi: 10.1155/2013/485272. PMID: 24348701
  21. Bazzichi L, Giacomelli C, Atzeni F, et al. One year in review: Fibromyalgia. Clin Exp Rheumatol. 2016 Jun;34(2)(Suppl 96):S145-149. PMID: 27157400
  22. Cruccu G, Garcia-Larrea L, Hanson P, et al. EAN guidelines on central neurostimulation therapy in chronic pain conditions. Eur J Neurol. 2016 Oct;23(10):1489-1499. doi: 10.1111/ene.13103. PMID: 27511815
  23. Goldenberg, DL. Clinical manifestations and diagnosis of fibromyalgia in adults. UpToDate. http://www.uptodate.com. 22 Nov 2017.
  24. Goldenberg, DL. Initial treatment of fibromyalgia in adults. UpToDate. http://www.uptodate.com. 06 Nov 2018.
  25. Goldenberg, DL. Treatment of fibromyalgia in adults not responsive to initial therapies. UpToDate. http://www.uptodate.com. 19 Jun 2018.
  26. Häuser W, Fitzcharles M. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018 Mar;20(1):53-62. PMID: 29946212
  27. Higgs JB. Fibromyalgia in Primary Care. Prim Care. 2018 Jun;45(2):325-341. doi: 10.1016/j.pop.2018.02.008. PMID: 29759127
  28. Jay GW, Barkin RL. Fibromyalgia. Dis Mon. 2015 Mar;61(3):66-111. doi: 10.1016/j.disamonth.2015.01.002. PMID: 25769552
  29. Kia S, Choy E. Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines. 2017 May;5(2). doi: 10.3390/biomedicines5020020. PMID: 28536363
  30. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724. PMID: 27377815
  31. Talotta R, Bazzichi L, Di Franco M, et al. One year in review 2017: fibromyalgia. Clin Exp Rheumatol. 2017 Jun;35(3)(Suppl 105):6-12. PMID: 28681712
  32. Turk DC, Vierck CJ, Scarbrough E, et al. Fibromyalgia: combining pharmacological and nonpharmacological approaches to treating the person, not just the pain. The Journal of Pain. 2008 Feb;9(2):99-104. doi: 10.1016/j.jpain.2007.08.006.
  33. Wolfe f, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-329. doi: 10.1016/j.semarthrit.2016.08.012. PMID: 27916278
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.